The US Food and Drug Administration said on Thursday that it wants to eliminate the use of chlorofluorocarbons (CFCs) in metered dose inhalers for epinephrine, which are used to provide temporary relief of occasional symptoms of mild asthma.
Advertisement
Under the proposal, epinephrine measured dose inhalers (MDIs) with CFCs would be taken off the market by the end of 2010, United Press International reported.
After the proposed change is published in the Federal Register, there will be a 60-day public comment period.
There don't appear to be any major technical barriers to formulating epinephrine as a product that doesn't release CFCs, FDA officials said.
It's believed that CFCs - banned from most consumer aerosol products in the US for years - damage the Earth's ozone layer, UPI reported. –(HealthDay)
Bookmark with:
What are social bookmarks?